
CDPQ invests in Biogroup-LCD
Canadian pension fund Caisse de Dépôt et Placement du Québec (CDPQ) has acquired a minority stake in France-based Biogroup-LCD, a network of medical and biology laboratories, according to press reports.
CDPQ has invested €180m through a capital increase, while founder and CEO Stephane Eimer retains a majority stake in the business, according to French publication Capital Finance.
CDPQ was not available for comment on the transaction.
Founded in 1998 and based in Saint-Denis, Biogroup-LCD manages 150 medical biology laboratories across France, employing 2,200 staff and 220 medical biologists, doctors and pharmacists. The company serves 20,000 patients every day, and offers 2,000 routine and specialised daily examinations. Biogroup-LCD recorded €400m in turnover last year, according to Capital Finance.
The Canadian pension fund's most recent investments in the region include industrial and manufacturing business Delachaux in June and industrial engineering firm Fives, in January.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater